- Report
- October 2024
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 299 Pages
Global
From €5181EUR$5,450USD£4,353GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Clinical Trials
- April 2024
- 220 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- December 2024
- 171 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- August 2024
- 168 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- August 2024
- 49 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- May 2024
- 133 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- September 2024
- 343 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2024
- 200 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- September 2024
- 128 Pages
Global
From €14255EUR$14,995USD£11,976GBP
- Report
- May 2020
- 185 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- March 2022
- 300 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- January 2023
- 125 Pages
Global
From €2367EUR$2,490USD£1,989GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- November 2021
- 101 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions of people worldwide. It is characterized by difficulty breathing, coughing, and wheezing. COPD is typically treated with a combination of medications, including bronchodilators, inhaled corticosteroids, and antibiotics. The COPD drug market is a subset of the larger respiratory drug market, which includes drugs used to treat asthma, allergies, and other respiratory conditions.
The COPD drug market is highly competitive, with a variety of companies offering different types of medications. Some of the major players in the market include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Novartis, and Merck. These companies offer a range of COPD medications, including bronchodilators, inhaled corticosteroids, and antibiotics. Other companies, such as Teva Pharmaceuticals and Mylan, also offer generic versions of these medications. Show Less Read more